Heart drug trial aims to stop dangerous Post-Surgery leak in kids
NCT ID NCT06833320
Summary
This study is testing if a common heart drug called propranolol can safely and effectively treat a serious complication called chylothorax in children recovering from heart surgery. Chylothorax is a buildup of fluid in the chest that can delay recovery. Researchers will give 50 children either propranolol or a placebo for 9 days to see if the drug helps reduce the fluid drainage faster than the body would heal on its own.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center/NewYork-Presbyterian
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.